SAN DIEGO, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, will present a corporate overview at the 43rd Annual J.P. Morgan Healthcare conference on Thursday, January 16, 2025, at 10:30 AM - 11:10 AM.
Read more at globenewswire.comSkye Bioscience to Present at J.P. Morgan Healthcare Conference
SKYE BIOSCIENCE INC
NASDAQ:SKYE (2/11/2025, 8:00:01 PM)
After market: 2.98 +0.09 (+3.11%)2.89
-0.54 (-15.74%)
SKYE Latest News and Analysis
12 hours ago - ChartmillTuesday's session: top gainers and losersIntrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
